Form 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 2, 2003

 

 

RIBAPHARM INC.

(Exact name of registrant as specified in charter)

 

Delaware

(State or other

jurisdiction of incorporation)

  

1-31294

(Commission

File Number)

  

95-4805655

(I.R.S. Employer

Identification No.)

 

3300 Hyland Avenue, Costa Mesa, CA

  

92626

(Address of Principal Executive Offices)

  

(Zip Code)

 

Registrant’s telephone number, including area code: (714) 427-6236

 

 

Item 5. Other Events and Required FD Disclosure.

 

The Registrant hereby incorporates by reference the contents of the press release of the Registrant, dated June 2, 2003, filed herewith as Exhibit 99.1.

 

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

 

(c) Exhibits

 

  99.1   Press Release of the Company dated June 2, 2003.

 

2

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

       

RIBAPHARM INC.

Date: June 3, 2003

      

By:

  

/s/            

               

Kim D. Lamon

President and Chief Executive Officer

 

3

 

EXHIBIT INDEX

 

99.1

   

Press Release of the Company, dated June 2, 2003.

 

 

4